Elevated soluble IL-2Rα, IL-8, and MIP-1β levels are associated with inferior outcome and are independent of MIPI score in patients with mantle cell lymphoma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Elevated soluble IL-2Rα, IL-8, and MIP-1β levels are associated with inferior outcome and are independent of MIPI score in patients with mantle cell lymphoma
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF HEMATOLOGY
Volume 89, Issue 12, Pages E223-E227
Publisher
Wiley
Online
2014-08-28
DOI
10.1002/ajh.23838
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Confirmation of the Mantle-Cell Lymphoma International Prognostic Index in Randomized Trials of the European Mantle-Cell Lymphoma Network
- (2014) Eva Hoster et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Significance of Pretreatment Serum Cytokines in Classical Hodgkin Lymphoma
- (2013) P. R. Marri et al. CLINICAL CANCER RESEARCH
- Single-Agent Lenalidomide in Patients With Mantle-Cell Lymphoma Who Relapsed or Progressed After or Were Refractory to Bortezomib: Phase II MCL-001 (EMERGE) Study
- (2013) Andre Goy et al. JOURNAL OF CLINICAL ONCOLOGY
- Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
- (2013) Mathias J Rummel et al. LANCET
- Cytokine patterns in patients with cancer: a systematic review
- (2013) Bodo E Lippitz LANCET ONCOLOGY
- Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
- (2013) Michael L. Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patients
- (2012) Stephen M. Ansell et al. AMERICAN JOURNAL OF HEMATOLOGY
- Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: A clinic-based case-control study
- (2012) Bridget Charbonneau et al. CYTOKINE
- Molecular pathogenesis of mantle cell lymphoma
- (2012) Pedro Jares et al. JOURNAL OF CLINICAL INVESTIGATION
- Circulating cytokine levels, Epstein-Barr viremia, and risk of acquired immunodeficiency syndrome-related non-Hodgkin lymphoma
- (2011) Charles S. Rabkin et al. AMERICAN JOURNAL OF HEMATOLOGY
- Soluble IL-2R facilitates IL-2-mediated immune responses and predicts reduced survival in follicular B-cell non-Hodgkin lymphoma
- (2011) Z.-Z. Yang et al. BLOOD
- Comprehensive analysis of tumor microenvironment cytokines in Waldenstrom macroglobulinemia identifies CCL5 as a novel modulator of IL-6 activity
- (2011) S. F. Elsawa et al. BLOOD
- B-Cell Stimulatory Cytokines and Markers of Immune Activation Are Elevated Several Years Prior to the Diagnosis of Systemic AIDS-Associated Non-Hodgkin B-Cell Lymphoma
- (2011) E. C. Breen et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Immunosuppressive CD14+HLA-DRlow/- monocytes in B-cell non-Hodgkin lymphoma
- (2010) Y. Lin et al. BLOOD
- Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study
- (2010) Yian Gu et al. CANCER CAUSES & CONTROL
- Plasma Cytokines and Future Risk of Non-Hodgkin Lymphoma (NHL): A Case-Control Study Nested in the Italian European Prospective Investigation into Cancer and Nutrition
- (2010) F. Saberi Hosnijeh et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- T regulatory cells control T-cell proliferation partly by the release of soluble CD25 in patients with B-cell malignancies
- (2010) Camilla A. Lindqvist et al. IMMUNOLOGY
- Vitamin D Insufficiency and Prognosis in Non-Hodgkin's Lymphoma
- (2010) Matthew T. Drake et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma
- (2010) T E Witzig et al. LEUKEMIA
- Serum soluble interleukin-2 receptor level and immunophenotype are prognostic factors for patients with diffuse large B-cell lymphoma
- (2009) Toshiaki Morito et al. CANCER SCIENCE
- Over-expression of CCL3 MIP-1α in a blastoid mantle cell lymphoma with hypercalcemia
- (2009) Norimichi Hattori et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation
- (2008) J. A. Burger et al. BLOOD
- The Interleukin-8 Pathway in Cancer
- (2008) D. J.J. Waugh et al. CLINICAL CANCER RESEARCH
- Cytokines as a key component of cancer-related inflammation
- (2008) Giovanni Germano et al. CYTOKINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started